Completed PHASE3 INTERVENTIONAL 2-arm NCT03661489

Efficacy and Safety of Remimazolam (CNS7056) Compared to Propofol for Intravenous Anesthesia During Elective Surgery

Phase III Confirmatory Efficacy and Safety Trial of Remimazolam (CNS7056) Compared With Propofol for Intravenous Anesthesia During Elective Surgery in ASA Class III/IV Patients

Sponsor: Creative Clinical Research GmbH

Conditions Anesthesia, Intravenous

Interventions Propofol Remimazolam

Updated 6 times since 2018 Last updated: May 27, 2020 Started: Jul 24, 2018 Primary completion: Apr 2, 2020 Completion: Apr 2, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Anesthesia, Intravenous, this trial is completed. The trial is conducted by Creative Clinical Research GmbH and has accumulated 6 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2020 — Jan 2021 [monthly]

Completed PHASE3

Status: Recruiting → Completed
Nov 2019 — Jun 2020 [monthly]

Recruiting PHASE3

▶ Show 1 earlier version

Oct 2018 — Nov 2019 [monthly]

Recruiting PHASE3

First recorded

Jul 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Creative Clinical Research GmbH
ORION Clinical Services
Paion UK Ltd.
Simbec Research

Data source: Paion UK Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Erlangen, Germany